| Literature DB >> 30893587 |
Xin Li1, Meng Deng2, Alex S Petrucelli1, Cheng Zhu3, Jinyao Mo4, Lu Zhang5, Jason W Tam1, Pablo Ariel6, Baoyu Zhao7, Song Zhang1, Hengming Ke3, Pingwei Li7, Nikolay V Dokholyan8, Joseph A Duncan4, Jenny P-Y Ting9.
Abstract
Immune suppression is a crucial component of immunoregulation and a subgroup of nucleotide-binding domain (NBD), leucine-rich repeat (LRR)-containing proteins (NLRs) attenuate innate immunity. How this inhibitory function is controlled is unknown. A key question is whether microbial ligands can regulate this inhibition. NLRC3 is a negative regulator that attenuates type I interferon (IFN-I) response by sequestering and attenuating stimulator of interferon genes (STING) activation. Here, we report that NLRC3 binds viral DNA and other nucleic acids through its LRR domain. DNA binding to NLRC3 increases its ATPase activity, and ATP-binding by NLRC3 diminishes its interaction with STING, thus licensing an IFN-I response. This work uncovers a mechanism wherein viral nucleic acid binding releases an inhibitory innate receptor from its target.Entities:
Keywords: DNA-binding receptor; NOD-like receptor; STING; TBK1; interferon
Mesh:
Substances:
Year: 2019 PMID: 30893587 PMCID: PMC6469509 DOI: 10.1016/j.immuni.2019.02.009
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745